Connect Biopharma
(NASDAQ) CNTB
Connect Biopharma Financials at a Glance
Market Cap
$152.06M
Revenue (TTM)
$26.08M
Net Income (TTM)
$57.39M
EPS (TTM)
$-0.28
P/E Ratio
-9.61
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$2.88
Volume
171,657
Open
$2.85
Price
$2.88
Volume
171,657
Open
$2.85
Previous Close
$2.87
Daily Range
$2.78 - $3.00
52-Week Range
$0.51 - $3.28
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$2.88
Volume
171,657
Open
$2.85
Previous Close
$2.87
Daily Range
$2.78 - $3.00
52-Week Range
$0.51 - $3.28
CNTB News
CNTB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Connect Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
62
CEO
Barry D. Quart, PharmD
Website
www.connectbiopharm.comHeadquarters
Taicang, 215400, CN
CNTB Financials
Key Financial Metrics (TTM)
Gross Margin
91%
Operating Margin
-20%
Net Income Margin
-18%
Return on Equity
0%
Return on Capital
-53%
Return on Assets
-44%
Earnings Yield
-10.41%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$152.06M
Shares Outstanding
55.90M
Volume
171.66K
Short Interest
0.00%
Avg. Volume
104.79K
Financials (TTM)
Gross Profit
$26.03M
Operating Income
$22.45M
EBITDA
$21.79M
Operating Cash Flow
$23.61M
Capital Expenditure
$750.00K
Free Cash Flow
$24.36M
Cash & ST Invst.
$93.71M
Total Debt
$178.00K
Connect Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$48.00K
N/A
Gross Profit
$48.00K
+109.5%
Gross Margin
100.00%
N/A
Market Cap
$152.06M
N/A
Market Cap/Employee
$2.45M
N/A
Employees
62
N/A
Net Income
$12.90M
+57.8%
EBITDA
$13.25M
+55.8%
Quarterly Fundamentals
Net Cash
$70.90M
-45.7%
Accounts Receivable
$193.00K
+284.1%
Inventory
$0.00
-100.0%
Long Term Debt
$520.00K
+61.8%
Short Term Debt
$700.00K
+158.6%
Return on Assets
-43.66%
N/A
Return on Invested Capital
-53.25%
N/A
Free Cash Flow
$12.89M
+58.9%
Operating Cash Flow
$12.59M
+59.5%